Author name: Leonardo Arias

Muscle Preservation, Tolerability and Alternative Administration Routes Define Obesity’s Drug Future

In the incredibly hot obesity drug space, with more than 700 clinical trials ongoing, Verdiva Bio and MitoRx leaders discuss how next-generation therapies are targeting lean muscle preservation, extended efficacy and better safety profiles to enable lifelong weight management.

Muscle Preservation, Tolerability and Alternative Administration Routes Define Obesity’s Drug Future Read More »

Scroll to Top